Rigor Reviewed

Rigor-Reviewed Manuscript

A Multicomponent Intervention to Improve Maternal Infection Outcomes.

Name: Αlpha¹ Rigor Record — A Multicomponent Intervention to Improve Maternal Infection Outcomes.
Item: A Multicomponent Intervention to Improve Maternal Infection Outcomes.
Rating: 59
Author: Αlpha¹

Lissauer D, Gadama L, Waitt C, Whyte S, Burnside G, Anilkumar A, Makuluni R, Okwaro P, Yang L, Waitt P, Musopole O, Bilesi R, Maseko B, Lwasa J, Mugahi R, Olaro C, Lamorde M, Makuta M, Kachiwaya C, Mkandawire T, Malunga A, Chitsulo N, Abitimo P, Ayabo T, Weeks A, Martin J, Hemming K, Gallos I, Monk EJM, Riches J, Chapuma C, Nanyondo S J, Lorencatto F, Monahan M, Allegranzi B, Dunlop C, Atkins L, Rosala-Hallas A, Roberts T, Gamble C, Malata A, Desmond N, Kommwa E, Merriel A, Parry-Smith W, Smith R, Ndumu I, Williams E, Faque B, Banda G, Nyondo-Mipando AL, Twimukye A, Chater T, Diplas A, Brizuela V, Souza JP, Rylance J, Cheshire J, Hawker L, Coomarasamy A, Bonet M

Paper source

Read full text (PMC)

Embed this Rigor badge

Αlpha¹ Rigor Review — 2.25★ (Weak), 0 critical, 6 high issues for “A Multicomponent Intervention to Improve Maternal Infection Outcomes.”

Links back to this Rigor Record.

Αlpha¹ Editorial

This rigor review was examined and confirmed by Αlpha¹ Editorial · August 10, 2026

Αlpha¹ Rigor Review

Rigor Reviewed

2.25 / 5

Weak — serious problems found

Interventional Study

Critical

High-priority

How this rating was calculated▸

Started at 5★ — deductions

IntegrityIntegrity concern ×3−1.5★
ReportingData & code availability not met−0.5★
ReportingBiological variables partially met−0.25★
ReportingEthical approvals partially met−0.25★
ReportingStatistical analysis partially met−0.25★

Model-reported confidence: highReviewer agreement: highEngine: 7.29.0Source: full text

Problems surfaced8 types

Numerical inconsistencies1

Values that contradict each other or are impossible for the stated sample: recomputed p-values and test statistics, GRIM/GRIMMER checks on summary numbers, percentages against their own counts, totals against their parts, and estimates against their own confidence intervals.

Internal contradictions in the reported numbersAssessed

Overstated conclusions1

Conclusions that reach past what the paper's own results support — including a significance claim that no longer holds when the statistic is recomputed, and efficacy resting on an unvalidated surrogate endpoint.

Conclusions only partially backed by the presented evidenceAssessed

Data authenticity concerns1

An adversarial read for patterns associated with data that may not be genuine: results that look too clean, implausibly large effects, duplicated data or images, and methods that do not match the results reported.

Possible duplicated data or imagesAssessed

Reporting gaps4

Required detail the manuscript never states — study design, biological variables, ethics approval and consent, key resources, statistical reporting, data and code availability, and overall transparency.

Data and code not sharedAssessed
Statistical reporting gaps (tests, assumptions, effect sizes)Assessed
Biological variables underreported (sex, age, strain)Assessed
Ethics/consent reporting incompleteAssessed

Copyediting1

Wording, consistency and formatting errors that need correcting before submission.

Wording or formatting errors that need correctingAssessed

This Αlpha¹ Rigor Review uses AI Rigor Reviewers trained on a curated corpus of high-fidelity and retracted papers, with expert supervision and curation. It can still make mistakes; verify each finding against the source before relying on it.

The paper reports a well-designed cluster-randomized trial with a strong scientific premise, rigorous design, and transparent reporting. The main weaknesses are the absence of a data availability statement (critical for a clinical trial), missing exact p-values and software identification, and incomplete reporting of patient demographics. Several copyedit issues (Table 1 data inconsistencies, typos) also need correction.

Two independent reviewer runs agreed on all dimension statuses, so synthesis was straightforward. The key resources dimension was deemed not applicable (behavioral intervention, no investigational product). The copyedit pass and integrity checks revealed minor data issues in Table 1 (identical counts for two delivery categories) and a rounding discrepancy; these are not validity threats but should be corrected via erratum. Verification components showed no citation or statistical errors.

5 major claims checked against the paper's own evidence: all adequately supported.

Recomputed 1 test: 1 consistent, 0 inconsistent; 1 via agent-written checks.

3 integrity concerns flagged (0 high).

Reporting

Eight Dimensions3 pass · 3 warn · 1 fail

Prior work is cited (WHO hand-hygiene and infection-prevention recommendations, sepsis bundles improving outcomes in other obstetric emergencies, maternal sepsis bundle developed for low-resource settings) with both strengths and the key weakness acknowledged ('its effect on maternal outcomes has not been established'). The rationale links the identified upstream deficiencies (inconsistent adherence, delays in recognition/treatment) to the three APT-Sepsis goals, and the hypothesis follows directly. Limitations of prior research (the unproven bundle effect) are explicitly the gap this trial is designed to fill.

Sub-criteria

prior work citedADEQUATE

premise rationaleADEQUATE

limitations addressedADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 90% conf

The paper establishes a clear scientific foundation: it cites prior evidence on maternal sepsis burden, WHO recommendations, and bundle effectiveness, identifies the specific evidence gap the trial addresses, and derives a logical rationale for the intervention.

Evidence

direct quote[Background]

“A maternal sepsis bundle has been developed specifically for low resource settings, but its effect on maternal outcomes has not been established.”